Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?

American Journal of Medicine

Volumn 106, Issue 3, 1999, Pages 300-306

  Mesler, Douglas E ^a   McCarthy, Ellen P ^a   Byrne Logan, Susan ^a   Ash, Arlene S ^a   Moskowitz, Mark A ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE MIX; CHRONIC KIDNEY FAILURE; DIALYSIS; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; DIAGNOSIS-RELATED GROUPS; FEMALE; HUMANS; MALE; MEDICARE; MIDDLE AGED; MINORITY GROUPS; MODELS, STATISTICAL; RENAL DIALYSIS; RISK; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; UNITED STATES;

EID: 0033106305     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00020-0     Document Type: Article

References (39)

1. USRDS 1997 Annual Data Report. 1997;The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md.
2. Levinsky N.G., Rettig R.A. Kidney Failure and the Federal Government Committee for the Study for the Medicare End-Stage Renal Disease Program . 1991;National Academy Press, Washington, DC.
3. Morbidity and mortality of renal dialysis an NIH consensus conference statement . Ann Intern Med. 121:1994;62-70.
4. Levinsky N.G., Mesler D.E. Measuring, managing and improving the quality of end-stage renal disease care. Am J Kidney Dis. 24:1994;235-246.
5. Held P.J., Port F.K., Turenne M.N., et al. Continuous ambulatory peritoneal dialysis and hemodialysis comparison of patient mortality with adjustment for comorbid conditions . Kidney Int. 45:1994;1163-1169.
6. Held P.J., Port F.K., Wolfe R.A., et al. The dose of hemodialysis and patient mortality. Kidney Int. 50:1996;550-556.
7. Owen W.F., Lew N.L., Liu Y., et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. NEJM. 329:1993;1001-1005.
8. Chertow B.M., Ling J., Lew N.L., et al. The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis. 24:1994;912-920.
9. Parker T.F., Wingard R.L., Husni L., et al. Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int. 49:1996;551-556.
10. Umen A.J., Le C. Prognostic factors, models and related statistical problems in the survival of end-stage renal disease patients on hemodialysis. Stat Med. 5:1986;637-652.
11. Eggers P.W. Mortality rates among dialysis patients in Medicare's end-stage renal disease program. Am J Kidney Dis. 15:1990;414-421.
12. Brogan D., Kutner N.G., Flagg E. Survival differences among older dialysis patients in the southeast. Am J Kidney Dis. 20:1992;376-386.
13. Furth S., Hermann J.A., Powe N.R. Cardiovascular risk factors, comorbidity, and survival outcomes in black and white dialysis patients. Semin Dialysis. 11:1998;102-105.
14. Lowrie E.G., Laird N.M., Parker T.F., Sargent J.A. Effect of the hemodialysis prescription on patient morbidity report from the National Cooperative Dialysis Study . NEJM. 305:1981;1176-1181.
15. Hutchinson T.A., Thomas D.C., McGibbon B. Predicting survival in adults with end-stage renal disease an age equivalence index . Ann Intern Med. 96:1982;417-423.
16. Held P.J., Levin N.W., Bovberg R.R., et al. Mortality and duration of hemodialysis treatment. JAMA. 265:1987;871-875.
17. Plough A.L., Salem S.R., Shwartz M., et al. Case mix in end-stage renal disease differences between patients in hospital-based and free-standing treatment facilities . NEJM. 310:1984;1432-1436.
18. Held P.J., Port F.K., Gaylin D.S., et al. Comorbid conditions and correlations with mortality risk among 3399 incident hemodialysis patients. Am J Kidney Dis. 20:(suppl 2):1992;32-38.
19. Khan I.H., Campbell M.K., Cantarovich D., et al. Comparing outcomes in renal replacement therapy how should we correct for case mix? Am J Kidney Dis. 31:1998;473-478.
20. Wolfe R.A., Gaylin D.S., Port F.K., et al. Using USRDS generated mortality tables to compare local end stage renal disease mortality rates to national rates. Kidney Int. 42:1992;991-996.
21. U.S. Renal Data system. USRDS 1992 Annual Data Report. Bethesda, Md: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1992.
22. Lee E.T. Statistical Methods for Survival Data Analysis. 2nd ed. 1992;Wiley & Sons, Inc, New York.
23. Sun G., Shook T.L., Kay G.L. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 49:1996;907-916.
24. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies development and validation . J Chron Dis. 40:1987;373-383.
25. Harrell F.E. Predicting Outcomes Applied Survival Analysis and Logistic Regression . 1994;Duke University Medical Center, Division of Biometry, Durham, NC.
26. SAS/STAT User's Guide, Version 6. Vols 1 and 2. 4th ed. 1992;SAS Institute, Cary, NC.
27. Marcelli D., Stannard D., Conte F., et al. ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the U.S. Kidney Int. 50:1996;1013-1018.
28. Bloembergen W.E., Port F.K., Mauger E.A., Wolfe R.A. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 6:1995;177-183.
29. Furth S., Hermann J.A., Powe N.R. Cardiovascular risk factors, comorbidity, and survival outcomes in black and white dialysis patients. Semin Dialysis. 11:1998;102-105.
30. Port F.K., Wolfe R.A., Mauger E.A., et al. Comparison of survival probabilities for dialysis patients vs. cadeveric renal transplant patients. JAMA. 270:1993;1339-1343.
31. Leggat J.E., Bloembergen W.E., Levine G., et al. An analysis of risk factors for withdrawal from dialysis prior to death. J Am Soc Nephrol. 7:1996;1391.
32. Witzig R. The medicalization of race scientific legitimization of a flawed social construct . Ann Intern Med. 125:1996;675-679.
33. Geronimus A.T., Bound J., Waidmann T.A., et al. Excess mortality among blacks and whites in the U.S. NEJM. 335:1996;1552-1558.
34. Eley J.W., Hill H.A., Chen V.W., et al. Racial differences in survival from breast cancer results of the National Cancer Institute Black/White Cancer Survival Study . JAMA. 272:1994;947-954.
35. Peterson E.D., Shaw L.K., DeLong E.R., et al. Racial variation in the use of coronary-revascularization procedures: are the differences real? Do they matter? NEJM. 336:1997;480-486.
36. Price D.A., Owen W.F. African-Americans on maintenance dialysis a review of racial differences in incidence, treatment, and survival . Adv Ren Replace Ther. 4:(1):1997;3-12.
37. Sherman R.A., Cody R.P., Solanchick J.C. Racial differences in the delivery of hemodialysis. Am J Kidney Dis. 21:1993;632-634.
38. Iezzoni L.I. The risks of risk adjustment. JAMA. 278:1997;1600-1607.
39. Knaus W.A., Wagner D.P., Draper E.A., et al. The APACHE III prognostic system risk prediction of hospital mortality for critically ill hospitalized adults . Chest. 100:1991;1619-1636.